Search results for "PEPTIDE"

showing 10 items of 4589 documents

Avances en el tratamiento de la hipercolesterolemia

2010

Advances in cholesterol-lowering interventions Abstract Numerous epidemiological and prospective studies have shown a direct relationship between total cholesterol and low-density lipoprotein cholesterol (LDL-C) and cardio- vascular disease (cardiovascular morbidity and mortality). In many intervention studies with more than 100,000 subjects, statins have shown a powerful and significant reduction of cardiovascular events and a decrease in cardiovascular and overall mortality, far superior to those produced by any other lipid-lowering group.

medicine.medical_specialtybusiness.industryVascular diseaseEndocrinology Diabetes and Metabolismmedicine.diseaseIntervention studiesEndocrinologyEndocrinologyInternal medicineTotal cholesterolEpidemiologymedicineCardiologylipids (amino acids peptides and proteins)businessProspective cohort studyLipoprotein cholesterolEndocrinología y Nutrición
researchProduct

Contrast-Induced Hyperemia and FFR: Slightly Slower but still “Quick and Clean”

2016

Slightly more complex than the previous one, a quick way to induce hyperemia is to inject a contrast bolus. Although the degree of hyperemia reached this way is not as large as with vasodilators, this maneuver can still allow unmasking a gradient.

medicine.medical_specialtybusiness.industryVasodilationbody regionsBolus (medicine)Internal medicinecardiovascular systemmedicineCardiologylipids (amino acids peptides and proteins)cardiovascular diseasesSevere stenosisbusinesscirculatory and respiratory physiology
researchProduct

Principles and Technique of Foam Sclerotherapy and Its Specific Use in the Treatment of Venous Leg Ulcers

2011

Invention of foam sclerotherapy has significantly changed the current phlebological practice. Compared with liquid sclerosants, obliterating foam is more efficient, especially for the closure of larger veins. This review discusses clinical aspects of foam sclerotherapy with a focus on its use for the treatment of venous leg ulceration, including the rationale for its use in the treatment of these chronic wounds, physicochemical mechanisms responsible for stability and disintegration of sclerosant foam, pathomechanism of neurologic adverse events seen after foam sclerotherapy, and techniques that can increase efficacy of this procedure and lower frequency of adverse events.

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentPhlebographyGeneral MedicineCarbon Dioxideleg ulcersVaricose UlcerSurgeryOxygenChronic diseaseChronic DiseaseSclerotherapyVaricose veinsmedicineSclerotherapyHumanslipids (amino acids peptides and proteins)Surgerycardiovascular diseasesfoam sclerotherapymedicine.symptombusinessAdverse effectvaricose veinsInternational Journal of Lower Extremity Wounds
researchProduct

Establishing cut-off values for apolipoprotein B and non-HDL-C according to LDL-C values in a South European population

2012

SUMMARY Background: Low-density lipoprotein cholesterol (LDL-C) remains the primary target of therapy in most strategies of dyslipidaemia management focused on cardiovascular disease prevention. Different guidelines have identified specific LDL-C cut-off points as targets for therapeutic intervention. Many clinical situations characterised by dyslipidaemia and elevated triglycerides are common in our environment and in overall industrialised countries. Thus, lipid goals based only on LDL-C could misclassify an important percentage of subjects. The objective of the present study was to establish cut-off point values for apoB and non-HDL-C in relation to the identified LDL-C cut-off points fo…

medicine.medical_specialtyeducation.field_of_studyApolipoprotein BbiologyCross-sectional studybusiness.industryCholesterolNon hdl cPopulationnutritional and metabolic diseasesGeneral MedicineEuropean populationchemistry.chemical_compoundEndocrinologychemistryInternal medicinemedicinebiology.proteinlipids (amino acids peptides and proteins)Young adultbusinesseducationLipoprotein cholesterolInternational Journal of Clinical Practice
researchProduct

2019

Cardiovascular disease (CVD) is the leading cause of death in patients with nonalcoholic fatty liver disease (NAFLD). The current analysis expands the knowledge on atherogenic lipid profiles in NAFLD by modeling changes in low-density lipoprotein cholesterol (LDL-C) and total cholesterol (TC) in a prospectively enrolling real-life study cohort to inform physicians on the cardiovascular (CV) event risk based on these changes. A total of 304 patients with histologically confirmed NAFLD were included (mean age, 52 years; equal sex distribution). Of these, 129 (42.4%) patients exhibited a NAFLD activity score ≥4 and 186 (61.2%) had at least intermediate fibrosis ≥F2. The median TC levels were 2…

medicine.medical_specialtyeducation.field_of_studyFramingham Risk ScoreHepatologybusiness.industryPopulationmedicine.diseaseGastroenterologyFibrosisInterquartile rangeInternal medicineCohortNonalcoholic fatty liver diseasemedicinelipids (amino acids peptides and proteins)In patienteducationbusinessCause of deathHepatology Communications
researchProduct

Making it More Sensitive

2011

About a decade ago, the prevailing wisdom was that conventional risk factors explained only approximately half of the risk for a myocardial infarction or stroke. Consequently, efforts to identify novel risk factors were undertaken to improve cardiovascular risk prediction. The hypothesis that inflammation is a central contributor to atherothrombosis has stimulated sustained efforts to characterize the specific molecules and pathways that may be involved and to identify biomarkers in humans that enable detection of underlying inflammatory activation to improve cardiovascular risk prediction. Ridker et al1 pioneered this work and reported that systemic low-grade inflammation assessed by measu…

medicine.medical_specialtyeducation.field_of_studybiologyTroponin Tbusiness.industrymedicine.drug_classPopulationDiseasemedicine.diseaseTroponinPhysiology (medical)Internal medicineHeart failureNatriuretic peptidebiology.proteinCardiologyMedicineMyocardial infarctionCardiology and Cardiovascular MedicinebusinesseducationStrokeCirculation
researchProduct

Low-density-lipoprotein peak particle size in a Mediterranean population

2003

Background The predominance of small, dense low-density lipoprotein (LDL) particles (‘LDL phenotype B’) has been associated with a three-fold increased risk of myocardial infarction, but the feasibility of the identification of small, dense LDL as independent predictors of coronary artery disease risk in population studies remains questioned. Design We evaluated the LDL peak particle size and its relation with other established risk factors for coronary heart disease in a group of 156 randomized subjects living on the Mediterranean island of Ustica (71 males and 85 women, range of age 20–69 years), representing approximately 30% of the total population. Results The prevalence of LDL phenoty…

medicine.medical_specialtyeducation.field_of_studybusiness.industryClinical BiochemistryPopulationGeneral Medicinemedicine.diseaseBiochemistrychemistry.chemical_compoundEndocrinologychemistryInternal medicineDiabetes mellitusLow-density lipoproteinmedicinelipids (amino acids peptides and proteins)Myocardial infarctionParticle sizeRisk factoreducationbusinessBody mass indexLipoproteinEuropean Journal of Clinical Investigation
researchProduct

Bone Turnover Markers and Potential Correlation with Outcomes in Patients with Genitourinary Cancer (Renal and Bladder) and Bone Metastasis (Results …

2012

ABSTRACT Background Levels of bone turnover markers (BTM) might be correlated with outcome in terms of skeletal related events (SRE), disease progression and death. The aim of the study was to determine the possible correlation between BTM, disease progression, SREs and death in patients with genitourinary cancer and bone metastases (BM) treated with zoledronic acid (ZA). Methods Observational, prospective, multicenter study. Patients with genitourinary cancer (prostate, renal, bladder) and BM were included. BTM determined were: carboxiterminal telopeptide of type I collagen (β-CTX) and bone specific alkaline phosphatase (BALP) by ELISA (immunoenzymatic assay, IDS UK), and aminoterminal pro…

medicine.medical_specialtyeducation.field_of_studybusiness.industryPopulationBone metastasisCancerHematologymedicine.diseaseLower riskGastroenterologyBone remodelingmedicine.anatomical_structureZoledronic acidOncologyN-terminal telopeptideProstateInternal medicinemedicinebusinesseducationmedicine.drugAnnals of Oncology
researchProduct

Changes in the Expression of Tachykinin Receptors in the Rat Uterus During the Course of Pregnancy1

2001

In the mammalian female reproductive tract, tachykinin neuropeptides, such as substance P (SP), are localized to a population of sensory fibers and their precise physiological role is still unknown. The aim of the present study was to characterize the population of tachykinin receptors in the pregnant rat uterus and to assess their regulation during the course of pregnancy and after delivery. The expression of the tachykinin NK(1) receptor (NK(1)R), the tachykinin NK(2) receptor (NK(2)R), and the tachykinin NK(3) receptor (NK(3)R) in uteri from rats at different stages of pregnancy and on Day 1 postpartum was investigated by using a semiquantitative reverse transcription-polymerase chain re…

medicine.medical_specialtyeducation.field_of_studymedicine.drug_classPopulationPhosphoramidonUterusNeuropeptideSubstance PCell BiologyGeneral MedicineBiologychemistry.chemical_compoundmedicine.anatomical_structureEndocrinologyReproductive MedicinechemistryEstrogenInternal medicinemedicineeducationTachykinin receptorReceptorBiology of Reproduction
researchProduct

Regulated Proteolysis of RAGE and AβPP as Possible Link Between Type 2 Diabetes Mellitus and Alzheimer's Disease

2009

Epidemiological studies have linked type 2 diabetes mellitus (T2DM) with an increased risk of developing Alzheimer's disease (AD). In T2DM, the elevated blood glucose level promotes formation of advanced glycation end products (AGEs). The receptor for AGEs (RAGE) is a type I membrane-protein and is also able to import amyloid-beta (Abeta) from the blood across the blood-brain-barrier into the brain. Oligomeric Abeta peptides disturb synaptic function in the brain and are believed to contribute to the development of AD. Abeta peptides are released from the amyloid-beta protein precursor (AbetaPP) after sequential proteolysis by beta- and gamma-secretases but alpha-secretase-mediated cleavage…

medicine.medical_specialtyendocrine system diseasesProteolysisReceptor for Advanced Glycation End ProductsAmyloid beta-Protein PrecursorAlzheimer DiseaseGlycationInternal medicinemental disordersmedicineAnimalsHumansReceptors ImmunologicProtein precursorProtein kinase AReceptorAmyloid beta-Peptidesmedicine.diagnostic_testChemistryGeneral Neurosciencenutritional and metabolic diseasesGeneral MedicinePsychiatry and Mental healthClinical PsychologyCholesterolEndocrinologyDiabetes Mellitus Type 2EctodomainPeptide transportAmyloid Precursor Protein SecretasesGeriatrics and GerontologySignal transductionJournal of Alzheimer's Disease
researchProduct